Serum Endocan in Systemic Lupus Erythematosus: Implication for Endothelial Dysfunction and Cardiovascular Risk

Key Points

• This research aims to explore the relationship between serum endocan levels and cardiovascular risk factors in systemic lupus erythematosus (SLE).
• Measured serum endocan levels in SLE patients
• Assessed endothelial function
• Evaluated subclinical atherosclerosis
• Elevated serum endocan levels were observed in SLE patients
• These levels correlated with signs of endothelial dysfunction
• Findings suggest an increased cardiovascular risk in this population